Big Pharma Abandoned Alzheimer’s, This Good Unicorn Stayed And Found A Potential Cure The biggest companies in the world gave up. Wall Street wrote it off as a lost cause. 17 years and hundreds of billions of dollars later, a potential cure for Alzheimer’s has finally been created...by a Good Unicorn. Let’s dive into the deep end with Martin Tolar, Founder and CEO of Alzheon.